Janux Therapeutics, Inc. announced that, under its collaboration with Bristol Myers Squibb, it has officially nominated a development candidate drug.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This development triggered the $35 million milestone payment clause stipulated in the cooperation agreement. The nomination of this drug candidate marks a substantial breakthrough in the collaboration between both parties in the field of tumor immunotherapy. The fulfillment of this milestone payment will further support Janux Therapeutics in advancing the research and development of its innovative therapy pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Strike accused of withdrawing $29.5 million and 1,939 BTC in advance
AiCoin•2026/05/20 12:55
Web3 user-generated content platform Tomoland raises $2 million in funding, led by Sky9 Capital
Odaily星球日报•2026/05/20 12:53
Report: Warren Urges Federal Reserve to Update Stress Tests to Reflect Oil Shock Risks
华尔街见闻•2026/05/20 12:52
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$77,537.38
+0.83%
Ethereum
ETH
$2,133.28
+0.76%
Tether USDt
USDT
$0.9990
-0.02%
BNB
BNB
$644.52
+0.61%
XRP
XRP
$1.37
-0.32%
USDC
USDC
$0.9997
-0.00%
Solana
SOL
$85.01
+0.37%
TRON
TRX
$0.3585
+0.86%
Dogecoin
DOGE
$0.1042
+0.03%
Hyperliquid
HYPE
$49.97
+4.35%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now